XENCOR, INC.
Patent Owner
Stats
- 96 US PATENTS IN FORCE
- 17 US APPLICATIONS PENDING
- Mar 13, 2018 most recent publication
Details
- 96 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 11,244 Total Citation Count
- Oct 15, 1999 Earliest Filing
- 135 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2016/0347,837 OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATIONMay 27, 16Dec 01, 16[C12P, C07K]
2016/0122,435 METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLSJan 11, 16May 05, 16[C07K]
2016/0068,588 ANTIBODIES WITH MODIFIED ISOELECTRIC POINTS AND IMMUNOFILTERINGSep 14, 15Mar 10, 16[C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9914778 Methods and compositions for inhibiting CD32B expressing cellsJul 10, 14Mar 13, 18[A61K, C12P, C07K]
9902773 Methods and compositions for inhibiting CD32b expressing cellsJul 10, 14Feb 27, 18[A61K, C12P, C07K]
9714282 Optimized Fc variants and methods for their generationMay 23, 14Jul 25, 17[C07H, C12P, C12N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0370,021 OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATIONAbandonedJun 14, 13Dec 18, 14[C07K]
2014/0294,812 FC VARIANTS THAT IMPROVE FCRN BINDING AND/OR INCREASE ANTIBODY HALF-LIFEAbandonedMar 13, 14Oct 02, 14[C07K]
2014/0161,790 ENGINEERED IMMUNOGLOBULINS WITH EXTENDED IN VIVO HALF-LIFEAbandonedNov 19, 13Jun 12, 14[C07K]
2012/0082,664 OPTIMIZED ANTIBODIES THAT TARGET CD19AbandonedAug 30, 11Apr 05, 12[A61K, C12N, A61P, C07K]
2012/0014,950 Antibodies That Specifically Bind to DR3AbandonedAug 24, 11Jan 19, 12[A61K, A61P, C07K]
2011/0236,969 METHODS OF GENERATING VARIANT PROTEINS WITH INCREASED HOST STRING CONTENT AND COMPOSITIONS THEREOFAbandonedMar 21, 11Sep 29, 11[C07H, C12N, C07K]
2011/0064,727 Immunoglobulin Variants Outside the Fc RegionAbandonedAug 20, 07Mar 17, 11[A61K, A61P, C07K]
2010/0317,834 IgG Immunoglobulin Variants with Optimized Effector FunctionAbandonedAug 24, 10Dec 16, 10[C07K]
2010/0222,272 Pharmaceutical Compositions for the Treatment of TNF-Alpha Related DisordersAbandonedJan 25, 10Sep 02, 10[A61K, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.